Communiqués Viskase Holdings, Inc.

Actions

VISK

US2939048011

Conteneurs et emballages hors papier

Marché Fermé - OTC Markets 21:59:03 13/08/2026			Varia. 5j.	Varia. 1 janv.
4,510 ^USD	+4,46%		+0,22%	-

03/08	Viskase Holdings, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
04/05	Viskase Companies, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

25/03	Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
24/03	Enzon Announces Reverse Stock Split	GL
19/03	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
16/03	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
11/03	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
09/03	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
27/02	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
30/01	Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger	GL
24/10/25	Enzon and Viskase Announce Amendment to Merger Agreement	GL
21/06/25	Enzon and Viskase Enter into Merger Agreement	AQ
21/06/25	Enzon and Viskase Enter into Merger Agreement	GL
05/05/23	ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
16/02/23	ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
06/01/23	ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K)	AQ
09/11/22	ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
04/08/22	ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
15/06/22	ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
26/04/22	ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
25/02/22	ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
05/11/21	ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
05/08/21	ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
08/06/21	Enzon Pharmaceuticals : CONTINENTAL STOCK TRANSFER & TRUST COMPANY (Form 8-K)	PU
08/06/21	ENZON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
04/05/21	ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
23/02/21	ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ